Zogenix files for $86.25 mln IPO
WASHINGTON, March 20 |
WASHINGTON, March 20 (Reuters) - Specialty pharmaceutical firm Zogenix Inc said on Thursday it is planning an initial public offering of as much as $86.25 million in common stock.
Banc of America Securities LLC, Leerink Swann, Thomas Weisel Partners LLC and Susquehanna Financial Group LLP will underwrite the IPO, according to a preliminary offering document filed with the Securities and Exchange Commission.
It is seeking a Nasdaq listing under the symbol "ZGNX." (Reporting by John Poirier; editing by Jeffrey Benkoe)
- Tweet this
- Share this
- Digg this